October 17, 2017 4:58 AM ET

Biotechnology

Company Overview of NanoCor Therapeutics, Inc.

Key Executives for NanoCor Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Sheila A. Mikhail J.D., M.B.A.8 RelationshipsCo-Founder, Acting Chief Executive Officer and Director--
Roger J. Hajjar Ph.D., M.D.21 RelationshipsScientific Founder and Board Member51
Evangelia Kranias Ph.D.8 RelationshipsScientific Founder and Board Member--
Jude Samulski Ph.d.8 RelationshipsScientific Founder and Director--

NanoCor Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Sheila A. Mikhail J.D., M.B.A. 8 RelationshipsNanoCor Therapeutics, Inc.--
Jude Samulski Ph.d. 8 RelationshipsNanoCor Therapeutics, Inc.--
Evangelia Kranias Ph.D. 8 RelationshipsNanoCor Therapeutics, Inc.--
Roger J. Hajjar Ph.D., M.D. 21 RelationshipsPrysm, Inc.51
Joshua Michael Hare M.D., FACC 42 RelationshipsBiscayne Pharmaceuticals, Inc.--
View All Board Members

NanoCor Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
390.0K
Bonus
242.8K
Total Short Term Compensation
486.0K
Total Value of Options
18.0M
Compensation as of Fiscal Year
NanoCor Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Silence Therapeutics plc Appoints Annalisa Jenkins as Non-Executive Chair of Board of Directors
October 16, 2017 6:00 AM ET
Ablynx, Inc. Appoints Daniel Schneider as General Manager
October 16, 2017 5:01 AM ET
Cellmid Limited Appoints Martin Cross as Non-Executive Director
October 15, 2017 9:47 PM ET
Navidea Biopharmaceuticals, Inc Announces Board Changes
October 13, 2017 8:01 PM ET
BioAegis Therapeutics, Inc. Hires Mark J. Dinubile as Chief Medical Officer
October 13, 2017 2:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NanoCor Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.